Historical perspective on mitochondrial medicine

Developmental Disabilities Research Reviews

Volumn 16, Issue 2, 2010, Pages 106-113

  DiMauro, Salvatore ^a   Garone, Caterina ^b  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Intergenomic signaling; Maternal inheritance; Mitochondria; Mitochondrial DNA

Indexed keywords

MITOCHONDRIAL DNA; TRANSFER RNA;

ALLOGENIC BONE MARROW TRANSPLANTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOSYMBIOSIS; GENE MUTATION; GENOMICS; HISTORY OF MEDICINE; HUMAN; INHERITANCE; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL ENCEPHALOMYOPATHY; MNGIE SYNDROME; PRIORITY JOURNAL; REVIEW;

EID: 77956247027     PISSN: 19405510     EISSN: 10982779     Source Type: Journal    
DOI: 10.1002/ddrr.102     Document Type: Review

References (139)

1. Alexander C, Votruba M, Pesch UEA, et al. 2000. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nature Genet 26:211-215.
2. Andreu AL, Hanna MG, Reichmann H, et al. 1999. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. New Engl J Med 341:1037-1044. (Pubitemid 29451799)
3. Antonicka H, Leary SC, Guercin G-H, et al. 2003a. Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and acount for multiple, early-onset clinical phenotypes associated with isolated COX deficiency. Hum Mol Genet 12:2693-2702.
4. Antonicka H, Mattman A, Carlson CG, et al. 2003b. Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. Am J Hum Genet 72:101-114. (Pubitemid 36056846)
5. Bardosi A, Creutzfeldt W, DiMauro S, et al. 1987. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol 74:248-258.
6. Barritt JA, Brenner CA, Malter HE, et al. 2001. Mitochondria in human offspring derived from ooplasmic transplantation. Hum Reprod 16:513-516.
7. Barth PG, Scholte HR, Berden JA, et al. 1983. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62:327-355.
8. Bione S, D'Adamo P, Maestrini E, et al. 1996. A novel X-linked gene. G4.5, is responsible for Barth syndrome. Nature Genet 12:385-389.
9. Blass JP, Avigan J, Uhlendorf BW. 1970. A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 49:423-432.
10. Blazquez A, Gil-Borlando MC, Moran M, et al. 2009. Infantile mitochondrial encephalomyopathy with unusual phenotype caused by a novel BCS1L mutation in an isolated complex III-deficient patient. Neuromusc Dis 19:143-146.
11. Bolender N, Sickmann A, Wagner R, et al. 2008. Multiple pathways for sorting mitochondrial precursor proteins. EMBO J 9:42-49.
12. Bourgeron T, Rustin P, Chretien D, et al. 1995. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genet 11:144-149.
13. Bykhovskaya Y, Casas KA, Mengesha E, et al. 2004. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303-1308.
14. Carelli V, Barboni P, Sadun AA. 2006. Mitochondrial ophthalmology. In:DiMauro S, Hirano M, Schon EA, editors. Mitochondrial medicine. London: Informa Healthcare. p 105-142.
15. Leu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J Biol Chem 275:19198-19209.
16. Cizkova A, Stranecky V, Mayr JA, et al. 2009. TMEM70 mutations cause isolated ATP synthase deficiency and eonatal mitochondrial encephalomyopathy. Nature Genet 40:1288-1290.
17. Claypool SM. 2009. Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function. Biochim Biophys Acta 1788:2059-2068.
18. Coenen MJH, Antonicka H, Ugalde C, et al. 2004. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. New Engl J Med 351: 2080-2086.
19. Craven L, Tuppen HA, Greggains GD, et al. 2010. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 465:82-85.
20. Darin N, Oldfors A, Moslemi A-R, et al. 2001. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 49:377-383. (Pubitemid 32202792)
21. Davey KM, Parboosingh JS, McLeaod DR, et al. 2006. Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-kike condition. J Med Genet 43:385-393.
22. De Meirleir L, Seneca S, Lissens W, et al. 2004. Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12. J Med Genet 41:120-124. (Pubitemid 38221750)
23. Delettre C, Lenaers G, Griffoin J-M, et al. 2000. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nature Genet 26:207-210.
24. Delettre C, Lenaers G, Pelloquin L, et al. 2002. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metab 75:97-107.
25. DiMauro S, Andreu AL. 2000. Mutations in mtDNA: are we scraping the bottom of the barrel? Brain Pathol 10:431-441.
26. DiMauro S, Bonilla E, Lee CP, et al. 1976. Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. J Neurol Sci 27:217-232.
27. DiMauro S, Bonilla E, Zeviani M, et al. 1985. Mitochondrial myopathies. Ann Neurol 17:521-538.
28. DiMauro S, Davidzon G. 2005. Mitochondrial DNA and disease. Ann Med 37:222-232.
29. DiMauro S, DiMauro-Melis PM. 1973. Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 182:929-931.
30. DiMauro S, Schon EA. 2008. Mitochondrial disorders in the nervous system. Annu Rev Neurosci 31:91-123.
31. Dunning CJ, McKenzie M, Sugiana C, et al. 2007. Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease. EMBO J 26:3227-3237.
32. Edvardson S, Shaag A, Kolesnikova O, et al. 2007. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 81:857-862. (Pubitemid 47596554)
33. Elliott HR, Samuels DC, Eden JA, et al. 2008. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254-260.
34. Engel AG, Angelini C. 1973. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science 179:899-902.
35. Engel WK, Cunningham CG. 1963. Rapid examination of muscle tissue: an improved trichrome stain method for fresh-frozen biopsy sections. Neurology 13:919-923.
36. Fellman V. 2002. The GRACILE syndrome, a neonatal lethal metabolic disorder with iron overload. Blood Cells Mol Dis 29:444-450.
37. Fernandez-Moreira D, Ugalde C, Smeets R, et al. 2007. X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy. Ann Neurol 61:73-83.
38. Fernandez-Vizarra E, Bugiani M, Carrara F, et al. 2007. Impaired complex III assembly associated with BCS1L gene mutations in isolated mitochondrial encephalomyopathy. Hum Mol Genet 16:1241-1252.
39. Fichera M, Lo Giudice M, Falco M, et al. 2004. Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 63:1108-1110. (Pubitemid 39287929)
40. Fukuhara N, Tokiguchi S, Shirakawa K, et al. 1980. Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities): disease entity or a syndrome? J Neurol Sci 47:117-133.
41. Gohil VM, Hayes P, Matsuyama S, et al. 2004. Cardiolipin biosynthesis and mitochondrial respiratory chain function are interdependent. J Biol Chem 279:42612-42618.
42. Gonatas NK, Shy GM. 1965. Childhood myopathies with abnormal mitochondria. In Proceedings of the Vth International Congress of Neuropathology, Vol. 100. Amsterdam: Excerpta Medica International Congress Series. p 606-612.
43. Goto Y, Nonaka I, Horai S. 1990. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651-653. (Pubitemid 120015131)
44. Hakonen AH, Isohanni P, Paetau A, et al. 2007. Recessive twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 130:3032-3040.
45. Hansen JJ, Durr A, Cournu-Rebeix I, et al. 2002. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 70:1328-1332. (Pubitemid 34450582)
46. Haut S, Brivet M, Touati G, et al. 2003. A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycemia and lactic acidosis. Hum Genet 113:118-122.
47. Haydar NA, Conn HL, Afifi A, et al. 1971. Severe hypermetabolism with primary abnormality of skeletal muscle mitochondria. Ann Int Med 74:548-558.
48. Hers HG. 1965. Inborn lysosomal diseases. Gastroenterology 48:625-633.
49. Hinson JT, Fantin VR, Schonberger J, et al. 2007. Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome. New Engl J Med 356:809-819.
50. Hirano M, Marti R, Casali C, et al. 2006. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67:1458-1460.
51. Hoefs SJG, Skjeldal OH, Rodenburg RJ, et al. 2010. Novel mutations in the NDUFS1 gene cause low residual activities in human complex I deficiencies. Mol Genet Metab 100:251-256.
52. Holt IJ, Harding AE, Morgan Hughes JA. 1988. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717-719. (Pubitemid 18062238)
53. Horvath R, Kemp JP, Tuppen HAL, et al. 2009. Molecular basis of infantile reversible cytochrome c oxidase deficiency. Brain 132:3165-3174.
54. Hudson G, Amati-Bonneau P, Blakely E, et al. 2008. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 131:329-337.
55. Hudson G, Carelli V, Spruijt L, et al. 2007. Clinical expression of Leber Hereditary optic neuropahy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet 81:228-233.
56. Jacobs HT, Turnbull DM. 2005. Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet 21:312-314. (Pubitemid 40726384)
57. Janssen RJ, Nijtmans LGJ, Heuvel LP, et al. 2006. Mitochondrial complex I: structure, function and pathology. J Inher Metab Dis 29:499-515.
58. Kadowaki T, Kadowaki H, Mori Y, et al. 1994. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. New Engl J Med 330:962-968.
59. Karpati G, Carpenter S, Engel AG. 1975. The syndrome of systemic carnitine deficiency. Neurology 25:16-24.
60. Kaukonen J, Juselius JK, Tiranti V, et al. 2000. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289:782-785. (Pubitemid 30650199)
61. King MP, Attardi G. 1989. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246:500-503.
62. King MP, Koga Y, Davidson M, et al. 1992. Defects in mitochondrial protein synthesis and respiratory chain activity segragate with the tRNALeu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Mol Cell Biol 12:480-490.
63. Lagier-Tourenne C, Tazir M, Lopez LC, et al. 2008. ADSK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 82:661-672.
64. Ledley FD, Jansen R, Nham SU, et al. 1990. Mutation eliminating mitochondrial leader sequence of methylmalonyl-CoA mutase causes mut0 methylmalonic acidemia. Proc Natl Acad Sci USA 87:3147-3150. (Pubitemid 20144971)
65. Longley MJ, Clark S, Man CYW, et al. 2006. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 78:1026-1034.
66. Lopez LC, Quinzii C, Schuelke M, et al. 2006. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaproneyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 79:1125-1129.
67. Luft R. 1994. The development of mitochondrial medicine. Proc Natl Acad Sci USA 91:8731-8738.
68. Luft R, Ikkos D, Palmieri G, et al. 1962. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 41:1776-1804.
69. Magen D, Georgopoulos C, Bross P, et al. 2008. Mitochondrial Hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet 83:30-42.
70. Mandel H, Szargel R, Labay V, et al. 2001. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nature Genet 29:337-341.
71. Manwaring N, Jones MM,Wang JJ, et al. 2007. Population prevalence of the MELAS A3243G mutation. Mitochondrion 7:230-233. (Pubitemid 46420125)
72. Massa V, Fernandez-Vizarra E, Alshahwan S, et al. 2008. Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am J Hum Genet 82:1281-1289.
73. Masucci JP, Davidson M, Koga Y, et al. 1995. In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNALys gene: two genotypes produce similar phenotypes. Mol Cell Biol 15:2872-2881.
74. McFarland R, Clark KM, Morris AAM, et al. 2002. Multiple neonatal deaths due to homoplasmic mitochondrial DNA mutation. Nature Genet 30:145-146.
75. Miller C, Saada A, Shaul N, et al. 2004. Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 56:734-738.
76. Mollet J, Delahodde A, Serre V, et al. 2008. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 82:623-630.
77. Mootha VK, Lepage P, Miller K, et al. 2003. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci USA 100:605-610.
78. Moraes CT, DiMauro S, Zeviani M, et al. 1989. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome 'see comments. N Engl J Med 320:1293-1299.
79. Moraes CT, Shanske S, Tritschler HJ, et al. 1991. MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 48:492-501. (Pubitemid 21903047)
80. Nass MMK, Nass S. 1963a. Intramitochondrial fibers with DNA characteristics. I. Fixation and electron staining reactions. J Cell Biol 19:593-612.
81. Nass S, Nass M. 1963b. Intramitochondrial fibers with DNA characteristics. II. Enzymatic and other hydrolytic treatments. J Cell Biol 19:613-629.
82. Nishigaki Y, Marti RA, Copeland WC, et al. 2003. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 111:1913-1921.
83. Nishino I, Spinazzola A, Hirano M. 1999. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689-692. (Pubitemid 129506238)
84. Ogilvie I, Kennaway NG, Shoubridge EA. 2005. A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. J Clin Invest 115:2784-2792.
85. Papadopoulou LC, Sue CM, Davidson MM, et al. 1999. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nature Genet 23:333-337.
86. Pavlakis SG, Phillips PC, DiMauro S, et al. 1984. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 16:481-488. (Pubitemid 14021826)
87. Pedrola L, Espert A, Wu X, et al. 2005. GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. Hum Mol Genet 14:1087-1094.
88. Petty RK, Harding AE, Morgan Hughes JA. 1986. The clinical features of mitochondrial myopathy. Brain 109:915-938.
89. Poulton J, Hirano M, Spinazzola A, et al. 2009. Collated mutations in mitochondrial DNA (mtDNA) depletion syndrome (excludingbthe mitochondrial gamma polymerase, POLG1). Biochim Biophys Acta 1792:1109-1112.
90. Quinzii C, Lopez de Munain A, Von-Moltke J, et al. 2008. Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency. FASEB J 22:1874-1885.
91. Quinzii C, Naini A, Salviati L, et al. 2006. A mutation in para-Hydoxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 78:345-349. (Pubitemid 43157573)
92. Roesch K, Curran SP, Tranebjaerg L, et al. 2002. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum Mol Genet 11:477-486.
93. Rotig A, Poulton J. 2009. Genetic causes of mitochondrial DNA depletion in humans. Biochim Biophys Acta 1792:1103-1108.
94. Rowland LP. 1994. Mitochondrial encephalomyopathies: lumping, splitting, and melding. In: Schapira AHV, DiMauro S, editors. Mitochondrial disorders in neurology. Oxford: Butterworth-Heinemann. p 116-129.
95. Saada A, Edvardson S, Rapaport M, et al. 2008. C6ORF66 is an assembly factor of mitochondrial complex I. Am J Hum Genet 82:32-38.
96. Saada A, Shaag A, Mandel H, et al. 2001. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nature Genet 29:342-344. (Pubitemid 33096463)
97. Saada A, Vogel RO, Hoefs SJ, et al. 2009. Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. Am J Hum Genet 84:718-727.
98. Sacconi S, Salviati L, Nishigaki Y, et al. 2008. A functionally dominant mitochondrial DNA mutation. Hum Mol Genet 17:1814-1820.
99. Sagan L. 1967. On the origin of mitosing cells. J Theor Biol 14:255-274.
100. Sarzi E, Goffart S, Serre V, et al. 2007. Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol 62:579-587.
101. Schaefer AM, McFarland R, Blakely E, et al. 2008. Prevalence of mitochondrial; DNA disease in adults, Ann Neurol 63:35-39.
102. Schaefer AM, Taylor RW, Turnbull DM, et al. 2004. The epidemiology of mitochondrial disorders - past, present and future. Biochim Biophys Acta 1659:115-120.
103. Schatz G, Haslbrunner E, Tuppy H. 1964. Deoxyribonucleic acid associated with yeast mitochondria. Biochem Biophys Res Commun 15:127-132.
104. Scheper GC, Klok vd, van Andel RJ, et al. 2007. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nature Genet 39:534-538.
105. Schlame M, Ren M. 2006. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 580:5450-5455. (Pubitemid 44465900)
106. Schwartz M, Vissing J. 2002. Paternal inheritance of mitohondrial DNA. New Engl J Med 347:576-580.
107. Sedlak E, Panda M, Dale MP, et al. 2006. Photolabeling of cardiolipin binding subunits within bovine heart cytochrome c oxidase. Biochemistry 45:746-754.
108. Servidei S. 2001. Mitochondrial encephalomyopathies: gene mutation. Neuromusc Disord 14:107-116.
109. Shankar SP, Fingert JH, Carelli V, et al. 2008. Evidence for a novel X-linked modifier locus for Leber hereditary optic neuropathy. Opthal Genet 29:17-24.
110. Shapira Y, Harel S, Russell A. 1977. Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism. Isr J Med Sci 13:161-164. (Pubitemid 8090523)
111. Shoffner JM, Lott MT, Lezza A, et al. 1990. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61:931-937. (Pubitemid 120035125)
112. Shy GM, Gonatas NK. 1964. Human myopathy with giant abnormal mitochondria. Science 145:493-496.
113. Shy GM, Gonatas NK. 1966. Two childhood myopathies with abnormal mitochondria. I. Megaconial myopathy; II. Pleoconial myopathy. Brain 89:133-158.
114. Skladal D, Halliday J, Thorburn DR. 2003. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126:1905-1912.
115. Smeitink J, van den Heuvel L. 1999. Protein biosynthesis '99: human mitochondrial complex I in health and disease. Am J Hum Genet 64:1505-1510.
116. Smeitink JAM, Sengers R, Trijbels FJM, et al. 2001. Human NADH:ubiquinone oxidoreductase. J Bioenerg Biomembr 33:259-266.
117. Smits P, Smeitink JAM, van den Heuvel B. 2010. Mitochondrial translation and beyond; Processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol DOI 10.1155/2010/737385.
118. Spelbrink JN, Li FY, Tiranti V, et al. 2001. Human mitochondrial DNA deletions associated with mutations in the gene encoding twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nature Genet 28:200-201.
119. Spinazzola I, Carrara F, Lamantea E, et al. 2009. Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inher Metab Dis 32:143-158.
120. Spiro AJ, Moore CL, Prineas JW, et al. 1970. A cytochrome-related inherited disorder of the nervous system and muscle. Arch Neurol 23:103-112.
121. Sugiana C, Pagliarini DJ, McKenzie M, et al. 2008. Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease. Am J Hum Genet 83:468-478.
122. Tachibana M, Sparman M, Sritanaudomchai H, et al. 2009. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 461:376-372.
123. Takakubo F, Cartwright P, Hoogenraad N, et al. 1995. An amino acid substitution in the pyruvate dehydrogenase E1a gene, affecting mitochondrial import of the precursor protein. Am J Hum Genet 57:772-780.
124. Taylor RW, Giordano C, Davidson MM, et al. 2003. A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited cardiomyopathy. J Am Coll Cardiol 41:1786-1796.
125. Tiranti V, D'Adamo P, Briem E, et al. 2004. Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74:239-252.
126. Tiranti V, Hoertnagel K, Carrozzo R, et al. 1998. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 63:1609-1621.
127. Valnot I, Osmond S, Gigarel N, et al. 2000a. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 67:1104-1109.
128. Valnot I, von Kleist-Retzow J-C, Barrientos A, et al. 2000b. A mutation in the human heme-A:farnesyltransferase gene (COX 10) causes cytochrome c oxidase deficiency. Hum Mol Genet 9:1245-1249.
129. Van Goethem G, Dermaut B, Lofgren A, et al. 2001. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nature Genet 28:211-212. (Pubitemid 32626018)
130. Vreken P, Valianpour F, Nijtmans LG, et al. 2000. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 279:378-382.
131. Wallace DC, Singh G, Lott MT, et al. 1988. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427-1430.
132. Willems JL, Monnens L, Trijbels J, et al. 1977. Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics 60:850-857. (Pubitemid 8249270)
133. Xu Y, Malhotra A, Ren M, et al. 2006. The enzymatic function of tafazzin. J Biol Chem 281:39217-39224.
134. Yu-Wai-Man P, Griffiths PG, Gorman GS, et al. 2010. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 133:771-786.
135. Zeviani M, Moraes CT, DiMauro S. 1988. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 38:1339-1346.
136. Zeviani M, Servidei S, Gellera C, et al. 1989. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339:309-311. (Pubitemid 19130698)
137. Zhang M, Mileykovskaya E, Dowhan W. 2005. Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria. J Biol Chem 280:29403-29408.
138. Zhu Z, Yao J, Johns T, et al. 1998. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nature Genet 20:337-343.
139. Zuchner S, Mersiyanova IV, Muglia M, et al. 2004. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nature Genet 36:449-451.